Oct 16 (Reuters) – The weight-loss drug market is booming, with biotech firms racing to capture a slice of the fast-growing sector dominated by Novo Nordisk and Eli Lilly. Analysts expect the
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Central bankers eye higher rates as AI boom fuels scramble for cash
* AI spending lifts demand before supply * Governments and firms compete for capital *…
'Wild-eyed' comedian Russell Brand tried to drag me into toilets, woman tells UK court
By Michael Holden LONDON, Oct 16 (Reuters) - One of six women who accuse Russell…
UK competition regulator targets Microsoft's business software grip
By Paul Sandle and Yadarisa Shabong LONDON, Oct 16 (Reuters) - Britain's competition watchdog proposed…
